Hey guys, if you missed it, United Natural Foods ($UNFI) just agreed to settle $39 million with investors over claims that the company hid how inflation-related inventory gains were boosting its profits. The settlement terms have already been submitted to …
This is one of my favorite companies, and one which has a potential pathway to a $1B+ MC (currently at $130M). **For serious investors** looking to invest at a great share price/MC, I recommend you **read every word of today's …
Heidmar (HMR) is a ship management company. It doesn't own vessels, it manages them commercially and technically for owners and takes a percentage of gross freight. Roughly 60 vessels under commercial management, 20 under technical. The setup: H1 2026 came …
My last post got a ton of traction, and it seems like the comment section was split 50/50. The bears are hyper-focused on the $139M net loss, but if you look closer at the actual business scaling, this looks like …
Execution → License Fee Coming. Ainos has completed the required VELDONA® technology transfer, triggering a $600K initial license fee due within 15 business days. Another contractual milestone delivered as we focus capital on scaling Chemical Intelligence. $AIMD #VELDONA
I’ve been seeing people here talk about different stocks and symbols and everything, but as someone new in the stocks market, I want to know how I can spot these opportunities. I want to be able to find these new …
Unlike most posts here, I’m not recommending you buy this stock today. I am only recommending you add it to your watchlist, as they’ve got a few catalysts coming up soon that will start generating revenue and potentially lead to …
Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.
Two studies published this week add support for $ACRV’s drug ACR-368(prexasertib) Study 1: CAF-1 / chromatin assembly + prexasertib study: https://www.biorxiv.org/content/10.64898/2026.09.27.754407v1 Study looked into CHK1 inhibition in cancer cells with defective chromatin assembly. Study shows that treatment with prexasertib let …